Ozempic babies: separating real fertility risk from TikTok myth

What did @jodiemacx actually say?

Straightforwardly: nothing about Ozempic, semaglutide, or GLP-1 medications. The entire transcript is song lyrics, something along the lines of a friendship or romance ballad with lines like "I'm more than just your friend now" and "without you I just couldn't breathe." There are zero medical claims in the spoken content of this video.

The hashtags tell a different story. #ozempicbaby and #semiglutide (a misspelling of semaglutide) place this video squarely in GLP-1 content territory on TikTok's algorithm. So the platform categorized it correctly, and viewers searching for Ozempic content may land here, but the creator did not actually make any health claims worth fact-checking.

This matters because TikTok's discovery engine treats hashtags as content signals. A video tagged #ozempicbaby showing up in someone's feed carries an implicit frame, even if the audio is pure pop lyrics.

Does the science back this up?

There is no scientific claim to evaluate from the transcript itself. But since viewers may arrive here expecting GLP-1 content, it is worth addressing what the #ozempicbaby hashtag typically signals, and whether that broader trend has any scientific grounding.

The "Ozempic baby" phenomenon refers to reports of unintended pregnancies among women using GLP-1 receptor agonists like semaglutide. The proposed mechanism is two-fold: GLP-1 agonists may reduce the absorption of oral contraceptives due to slowed gastric emptying (a well-documented pharmacological effect), and significant weight loss itself can restore ovulatory cycles in women with obesity-related anovulation.

A 2023 case series from Jennings et al. in Frontiers in Endocrinology documented several cases fitting this pattern. The FDA label for semaglutide does note delayed gastric emptying as a side effect, though it stops short of a formal contraceptive interaction warning. The clinical picture is plausible, if not yet confirmed by large controlled trials.

What did they get wrong (or right)?

The creator did not get anything medically wrong because they did not say anything medical. That is both the conclusion and the problem with this video.

What is worth flagging is the hashtag strategy. Using #ozempicbaby and a misspelled drug name as discoverability tools, while posting unrelated content, contributes to the low-signal noise around GLP-1 medications on social media. Researchers studying health misinformation, including Basch et al. (2023, Journal of Medical Internet Research), have noted that TikTok's GLP-1 content ecosystem is heavily skewed toward anecdote, aesthetic transformation, and algorithm gaming rather than accurate clinical information.

There is nothing malicious here, and a 1,300-view video with song lyrics is not a public health threat. But the tagging behavior is a small example of how drug-adjacent hashtags dilute the information environment for people genuinely trying to research medications like Wegovy or Ozempic.

What should you actually know?

If the #ozempicbaby hashtag brought you here, here is what the evidence actually supports. GLP-1 receptor agonists cause significant weight loss in many patients, and weight loss can restore fertility in women who had stopped ovulating due to obesity. That is real. The contraceptive interaction concern is real enough that several reproductive endocrinologists now advise patients on semaglutide to use backup contraception, particularly during the first 4 weeks after a dose increase when nausea and vomiting peak.

Semaglutide is also contraindicated during pregnancy. The drug carries an animal-study-based warning about fetal harm, and the manufacturer recommends discontinuing it at least 2 months before a planned pregnancy. If you are using a GLP-1 agonist and are of reproductive age, this is a conversation to have with a prescribing clinician, not something to navigate based on TikTok tags.

FormBlends recommends speaking with a licensed provider before starting, stopping, or adjusting any GLP-1 medication.